论文部分内容阅读
目的探讨喘乐宁雾化吸入治疗急性支气管哮喘的疗效。方法对2008年2月至2010年2月收治86例急性支气管哮喘患者,随机分为治疗组与对照组。结果对照组和治疗组疗效分别为72.1%和90.7%,治疗组有效率明显高于对照组(P<0.05);且治疗后治疗组FEV1和PEFR改善情况优于对照组,相比差异有统计学意义(P<0.05)。结论急性支气管哮喘患者在常规治疗基础上使用雾化吸入喘乐宁治疗效果显著,且操作简便,值得临床广泛应用。
Objective To investigate the efficacy of inhalation of salbutamol in the treatment of acute bronchial asthma. Methods From February 2008 to February 2010, 86 patients with acute bronchial asthma were randomly divided into treatment group and control group. Results The efficacy of the control group and the treatment group were 72.1% and 90.7%, respectively, and the effective rate of the treatment group was significantly higher than that of the control group (P <0.05). After treatment, the improvement of FEV1 and PEFR in the treatment group was better than that in the control group Significance (P <0.05). Conclusion Acute bronchial asthma patients treated with inhalation of asthma on the basis of routine treatment have a significant effect, and the operation is simple and should be widely used clinically.